Patient body fat and AI ensemble technique and the influence on false-positive rate in AI second observer for colorectal cancer detection.

N Neal Kucera (Univesity of Nebraska College of Medicine, Omaha, NE) B Brandon Salinel (Banner MD Anderson Cancer Center, Gilbert, AZ) M Matthew Grudza (Arizona State University, Tempe, AZ) S Sarah Zeien (A.T. Still University of Health Sciences, Kirksville, MO) M Matthew Murphy (Clearview Healthcare Partners) J Jake Adkins (The University of Texas MD Anderson Cancer Center, Houston, TX) C Corey Jensen (The University of Texas MD Anderson Cancer Center, Houston, TX) C Curt Bay (AT Still University, Kirksville, MO) V Vikram Kodibagkar (Arizona State University, Tempe, AZ) P Phillip Koo (1Bristol Myers Squibb, Princeton, United States) M Michael A. Choti (Banner Health, Gilbert, AZ) M Madappa N. Kundranda (Banner MD Anderson Cancer Center, Gilbert, AZ) H Hongzhi Wang J John Chang (Kaiser Permanente Southern California, Pasadena, CA)

Abstract

216 Background: Colorectal cancer (CRC) is the second leading cause of cancer-related deaths. We previously found that delayed diagnosis due to lack of radiological identification results in significantly worse outcome for patients. We had developed a rudimentary, AI second observer which demonstrated potential for detecting CRC on routine CT abdomen/pelvis (CTAP). However, the AI algorithm detected many false positives. In this study, we analyzed the data using TCIA as test cases and evaluated whether patient peritoneal fat content influenced the false positive rate. This could serve as a guide for future training of AI second observer to minimize false positive detection. Methods: 2D U-Net convolutional neural network (CNN) containing 31 million trainable parameters was trained with 58 CRC CT images from Banner MD Anderson (AZ) and MD Anderson Cancer Center (TX) (51 used for training and 7 for validation) and 59 normal CT scans from Banner MD Anderson Cancer Center. 18 of the 25 CRC cases from public domain data (The Cancer Genome Atlas) were used to evaluate the performance of the models (5 had no identifiable cancer and 2 were rejected for having no contrast). The CRC was segmented using ITK-SNAP open-source software (v. 3.8). To apply the deep ensemble approach, five CNN models were trained independently with random initialization using the same U-Net architect and the same training data. Given a testing CT scan, each of the five trained CNN models was applied to produce tumor segmentation for the testing CT scan. The tumor segmentation results produced by the trained CNN models were then fused using a simple majority voting rule (up to 2 voters) to produce consensus tumor segmentation results. The segmentation was analyzed for the number and location of false positives per case. The peritoneal fat content was classified at the level of aortic bifurcation by the distance of fat between adjacent small bowel loops (≤ or > 1 cm). Chi-square test was performed testing fat volume and number of voters as the intervention. Results: Our results showed that the higher volume of peritoneal fat (> 1 cm, N=6) decreases the rate of false positive compared with low volume (≤ 1 cm, N=12, p=0.013). When comparing between having one voter and two voter ensemble using low fat volume data, two voter ensemble also decreased the number of false positives but not statistically significant (p=0.286). Conclusions: Our results show that AI-based second observer generates more false positives when patients have lower peritoneal fat volume; this implies that future training may require higher percentage of cases with low peritoneal fat to improve second observer precision. Our analysis also showed that increasing the number of voter in the ensemble also decrease the number of false positives per case.

Article Details

Volume / Issue Vol. 43, Issue 4_suppl
Published February 01, 2025
Pages 216-216
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (14)

N

Neal Kucera

Univesity of Nebraska College of Medicine, Omaha, NE

B

Brandon Salinel

Banner MD Anderson Cancer Center, Gilbert, AZ

M

Matthew Grudza

Arizona State University, Tempe, AZ

S

Sarah Zeien

A.T. Still University of Health Sciences, Kirksville, MO

M

Matthew Murphy

Clearview Healthcare Partners

J

Jake Adkins

The University of Texas MD Anderson Cancer Center, Houston, TX

C

Corey Jensen

The University of Texas MD Anderson Cancer Center, Houston, TX

C

Curt Bay

AT Still University, Kirksville, MO

V

Vikram Kodibagkar

Arizona State University, Tempe, AZ

P

Phillip Koo

1Bristol Myers Squibb, Princeton, United States

M

Michael A. Choti

Banner Health, Gilbert, AZ

M

Madappa N. Kundranda

Banner MD Anderson Cancer Center, Gilbert, AZ

H

Hongzhi Wang

J

John Chang

Kaiser Permanente Southern California, Pasadena, CA